BeStock  
Stocks › Biotechnology › HELP

Cybin HELP

US equityMarket cap rank #3441Biotechnology
$10.51 −$0.25 (-2.32%)
Pre-market · Oct 8, 8:20 am ET · After hours $10.83 +3.04%
Open$10.63
Prev close$10.76
Day range$10.44 – $10.81
Volume832.1K
Market cap$767.86M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q1, ended Jun 2026

Revenue$0.00
Operating profit-$49.08M-99.3% YoY
Net profit-$47.82M-94.3% YoY
Diluted EPS-$0.91+17.3% YoY
Free cash flow-$37.39M-25.6% YoY
Operating cash flow-$37.07M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-41.9MSep '24$-7.5MDec '24$-21.3MMar '25$-24.6MJun '25$-33.7MSep '25$-42.7MDec '25$-47.0MMar '26$-47.8MJun '26

Diluted EPS by quarter

-2.10Sep '24-0.38Dec '24-1.03Mar '25-1.10Jun '25-1.39Sep '25-1.00Dec '25-0.85Mar '26-0.91Jun '26

Free cash flow by quarter

$-19.4MSep '24$-18.8MDec '24$-15.5MMar '25$-29.8MJun '25$-34.9MSep '25$-32.3MDec '25$-37.6MMar '26$-37.4MJun '26

Annual revenue

$684.5KFY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25$0.0FY26

Profitability & balance sheet

Return on equity-86.9%
Return on assets-72.8%
Return on invested capital-89.7%
Current ratio10.97
Liabilities / assets6.8%
Cash & investments$166.37M
Net cash (debt)$166.37M

Income statement

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $49.08M $142.59M $47.86M $41.21M $28.89M
Selling and Admin Expenses $18.32M $56.00M $18.97M $17.35M $10.04M
-General & Admin Expense $18.32M $49.55M $14.33M $16.28M $9.70M
Research & Development $30.76M $86.59M $28.89M $23.86M $18.85M
Operating Profit -$49.08M -$142.59M -$47.86M -$41.21M -$28.89M
Net Non-Operating Interest Income (Expense) $1.28M $2.18M $1.58M $1.50M $1.07M
Non-Operating Interest Income $1.28M $5.10M $1.58M $1.50M $1.07M
Other Income (Expense) -$19,000.00 -$7.59M -$714,000.00 -$2.96M -$5.89M
Gain on Sale of Security -$19,000.00 -$5.01M -$714,000.00 -$345,000.00 -$5.89M
Pretax Profit -$47.82M -$148.00M -$47.00M -$42.67M -$33.72M
Net Profit -$47.82M -$148.00M -$47.00M -$42.67M -$33.72M
Profit from Continuing Operations -$47.82M -$148.00M -$47.00M -$42.67M -$33.72M
Net Income to Parent Company -$47.82M -$148.00M -$47.00M -$42.67M -$33.72M
Net Income to Common Stockholders -$47.82M -$148.00M -$47.00M -$42.67M -$33.72M
Basic EPS -$0.91 -$4.25 -$0.85 -$1.00 -$1.39
Diluted EPS -$0.91 -$4.25 -$0.85 -$1.00 -$1.39
-Selling & Marketing Expense – $6.45M $4.65M $1.07M $349,000.00
Total Other Finance Costs – $2.92M $0.00 – –
Other Non-Operating Income (Expenses) – -$2.59M $0.00 -$2.62M –

Balance sheet

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Assets $259.66M $251.17M $251.17M $290.11M $181.25M
Total Current Assets $192.70M $184.52M $184.52M $222.90M $114.58M
Cash and Cash Equivalents & Short-Term Investments $166.37M $157.26M $157.26M $195.13M $83.75M
-Cash and Cash Equivalents $166.37M $157.26M $157.26M $195.13M $83.75M
Receivables $5.04M $5.03M $5.03M $4.77M $4.74M
-Accounts Receivable $5.04M $5.03M $5.03M $4.77M $4.74M
Prepaid Assets $21.29M $22.24M $22.24M $21.58M $24.42M
Total Non-Current Assets $66.96M $66.64M $66.64M $67.22M $66.67M
Net PPE $180,000.00 $195,000.00 $195,000.00 $186,000.00 $125,000.00
-Gross PPE $820,000.00 $811,000.00 $811,000.00 $796,000.00 $720,000.00
-Accumulated Depreciation -$640,000.00 -$616,000.00 -$616,000.00 -$610,000.00 -$595,000.00
Goodwill and Other Intangible Assets $66.78M $66.45M $66.45M $67.03M $66.54M
-Goodwill $36.24M $36.23M $36.23M $36.59M $36.51M
-Other Intangible Assets $30.54M $30.22M $30.22M $30.44M $30.03M
Total Liabilities $17.57M $19.38M $19.38M $16.18M $42.25M
Total Current Liabilities $17.57M $19.38M $19.38M $16.18M $13.36M
Total Non-Current Liabilities $0.00 $0.00 $0.00 $0.00 $28.89M
Total Equity $242.09M $231.79M $231.79M $273.93M $139.00M
Stockholders' Equity $242.09M $231.79M $231.79M $273.93M $139.00M
Capital Stock $538.87M $492.10M $492.10M $482.73M $353.59M
-Common Stock $538.87M $492.10M $492.10M $482.73M $353.59M
Additional Paid-In Capital $50.68M $34.97M $34.97M $33.01M $32.15M
Retained Earnings -$437.35M -$389.54M -$389.54M -$342.54M -$299.87M
Gains/Losses Not Affecting Retained Earnings $19.33M $8.08M $8.08M $4.63M $736,000.00
Other Equity Interests $70.56M $86.17M $86.17M $96.11M $52.39M
Other Current Assets – – – $1.42M $1.67M
Long Term Debt and Capital Lease Obligation – – – – $28.89M
-Long Term Debt – – – – $28.89M

Cash flow

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Operating Cash Flow -$37.07M -$133.27M -$37.29M -$31.95M -$34.49M
Net cash flow from continuing operations -$37.07M -$133.27M -$37.29M -$31.95M -$34.49M
Net Income from Continuing Operations -$47.82M -$148.00M -$47.00M -$42.67M -$33.72M
Gain/Loss from Continuing Operations $19,000.00 -$499,000.00 $714,000.00 -$17,000.00 $755,000.00
Depreciation & Depletion & Amortization $31,000.00 $120,000.00 $31,000.00 $22,000.00 $29,000.00
Change in Working Capital -$875,000.00 -$1.26M $3.70M $5.88M -$7.06M
-Change in Receivables -$10,000.00 -$934,000.00 -$262,000.00 -$31,000.00 -$630,000.00
-Change in Prepaid Assets $944,000.00 -$6.82M -$658,000.00 $2.84M -$5.26M
-Change in Payables and Accrued Expense -$1.81M $4.48M $3.20M $2.82M -$1.19M
-Change in Other Current Assets $0.00 $2.02M $1.42M $248,000.00 $17,000.00
Net cash flow from investing -$320,000.00 -$1.36M -$323,000.00 -$383,000.00 -$436,000.00
Net Cash Flow from Continuing Investing Activities -$320,000.00 -$1.36M -$323,000.00 -$383,000.00 -$436,000.00
Net PPE Purchase and Sale -$320,000.00 -$1.36M -$323,000.00 -$383,000.00 -$436,000.00
Financing Cash Flow $46.53M $198.24M -$169,000.00 $143.75M $27,000.00
Net Cash Flow from Continuing Financing Activities $46.53M $198.24M -$169,000.00 $143.75M $27,000.00
Net Issuance Payments Of Debt $0.00 $24.35M $0.00 -$20.15M $0.00
Net Common Stock Issuance $46.53M $146.05M $0.00 $135.92M $0.00
Ending Cash Balance $166.37M $157.26M $157.26M $195.13M $83.75M
Net Change in Cash $9.14M $63.61M -$37.78M $111.42M -$34.89M
Beginning Cash Balance $157.26M $93.92M $195.13M $83.75M $118.69M
Effect of Exchange Rate Changes -$36,000.00 -$269,000.00 -$87,000.00 -$42,000.00 -$46,000.00
Free Cash Flow -$37.39M -$134.64M -$37.61M -$32.33M -$34.92M
Proceeds from Stock Option Exercised – $28.15M $199,000.00 $27.90M –
Net Other Financing Charges – -$315,000.00 -$368,000.00 $79,000.00 –

Discussion

No comments yet — be the first to weigh in on HELP.

Leave a comment

Scroll to Top